nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.22	0.601	CbGbCtD
Valsartan—CYP2C9—Progesterone—uterine cancer	0.145	0.398	CbGbCtD
Valsartan—AGTR1—artery—uterine cancer	0.0122	0.189	CbGeAlD
Valsartan—AGTR1—myometrium—uterine cancer	0.00587	0.0911	CbGeAlD
Valsartan—SLCO1B3—vagina—uterine cancer	0.00511	0.0792	CbGeAlD
Valsartan—AGTR1—epithelium—uterine cancer	0.00461	0.0715	CbGeAlD
Valsartan—AGTR1—uterine cervix—uterine cancer	0.00457	0.0709	CbGeAlD
Valsartan—AGTR1—smooth muscle tissue—uterine cancer	0.00444	0.0689	CbGeAlD
Valsartan—AGTR1—decidua—uterine cancer	0.00435	0.0676	CbGeAlD
Valsartan—AGTR1—renal system—uterine cancer	0.00428	0.0664	CbGeAlD
Valsartan—SLCO1B1—renal system—uterine cancer	0.00408	0.0633	CbGeAlD
Valsartan—AGTR1—female reproductive system—uterine cancer	0.00342	0.0531	CbGeAlD
Valsartan—SLCO1B1—female reproductive system—uterine cancer	0.00326	0.0507	CbGeAlD
Valsartan—AGTR1—vagina—uterine cancer	0.0031	0.0481	CbGeAlD
Valsartan—AGTR1—lymph node—uterine cancer	0.002	0.0311	CbGeAlD
Valsartan—CYP2C9—female reproductive system—uterine cancer	0.00165	0.0256	CbGeAlD
Valsartan—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00283	CcSEcCtD
Valsartan—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00282	CcSEcCtD
Valsartan—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.0028	CcSEcCtD
Valsartan—Blood urea increased—Epirubicin—uterine cancer	0.00156	0.00274	CcSEcCtD
Valsartan—ALB—lymph node—uterine cancer	0.00155	0.024	CbGeAlD
Valsartan—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00268	CcSEcCtD
Valsartan—Myalgia—Dactinomycin—uterine cancer	0.00152	0.00267	CcSEcCtD
Valsartan—Hypersensitivity—Progesterone—uterine cancer	0.00152	0.00266	CcSEcCtD
Valsartan—Hyperkalaemia—Doxorubicin—uterine cancer	0.00151	0.00264	CcSEcCtD
Valsartan—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0026	CcSEcCtD
Valsartan—Asthenia—Progesterone—uterine cancer	0.00148	0.00259	CcSEcCtD
Valsartan—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00259	CcSEcCtD
Valsartan—Urinary tract disorder—Etoposide—uterine cancer	0.00147	0.00257	CcSEcCtD
Valsartan—Pruritus—Progesterone—uterine cancer	0.00146	0.00256	CcSEcCtD
Valsartan—Oedema—Dactinomycin—uterine cancer	0.00146	0.00256	CcSEcCtD
Valsartan—Urethral disorder—Etoposide—uterine cancer	0.00146	0.00255	CcSEcCtD
Valsartan—Infection—Dactinomycin—uterine cancer	0.00145	0.00254	CcSEcCtD
Valsartan—Blood urea increased—Doxorubicin—uterine cancer	0.00145	0.00254	CcSEcCtD
Valsartan—Thrombocytopenia—Dactinomycin—uterine cancer	0.00143	0.0025	CcSEcCtD
Valsartan—Diarrhoea—Progesterone—uterine cancer	0.00141	0.00247	CcSEcCtD
Valsartan—Anorexia—Dactinomycin—uterine cancer	0.00139	0.00244	CcSEcCtD
Valsartan—Cardiac disorder—Etoposide—uterine cancer	0.00138	0.00242	CcSEcCtD
Valsartan—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00241	CcSEcCtD
Valsartan—Photosensitivity—Epirubicin—uterine cancer	0.00137	0.0024	CcSEcCtD
Valsartan—Dizziness—Progesterone—uterine cancer	0.00136	0.00239	CcSEcCtD
Valsartan—Angiopathy—Etoposide—uterine cancer	0.00135	0.00236	CcSEcCtD
Valsartan—Immune system disorder—Etoposide—uterine cancer	0.00134	0.00235	CcSEcCtD
Valsartan—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00235	CcSEcCtD
Valsartan—Mediastinal disorder—Etoposide—uterine cancer	0.00134	0.00235	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00133	0.00233	CcSEcCtD
Valsartan—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00232	CcSEcCtD
Valsartan—Alopecia—Etoposide—uterine cancer	0.00131	0.0023	CcSEcCtD
Valsartan—Vomiting—Progesterone—uterine cancer	0.00131	0.0023	CcSEcCtD
Valsartan—Renal failure acute—Epirubicin—uterine cancer	0.0013	0.00228	CcSEcCtD
Valsartan—Rash—Progesterone—uterine cancer	0.0013	0.00228	CcSEcCtD
Valsartan—Dermatitis—Progesterone—uterine cancer	0.0013	0.00228	CcSEcCtD
Valsartan—Headache—Progesterone—uterine cancer	0.00129	0.00226	CcSEcCtD
Valsartan—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00224	CcSEcCtD
Valsartan—Photosensitivity—Doxorubicin—uterine cancer	0.00127	0.00222	CcSEcCtD
Valsartan—Decreased appetite—Dactinomycin—uterine cancer	0.00127	0.00222	CcSEcCtD
Valsartan—Dysgeusia—Etoposide—uterine cancer	0.00127	0.00222	CcSEcCtD
Valsartan—Renal impairment—Epirubicin—uterine cancer	0.00126	0.00222	CcSEcCtD
Valsartan—Dermatitis bullous—Epirubicin—uterine cancer	0.00126	0.00221	CcSEcCtD
Valsartan—Fatigue—Dactinomycin—uterine cancer	0.00126	0.0022	CcSEcCtD
Valsartan—Back pain—Etoposide—uterine cancer	0.00125	0.00219	CcSEcCtD
Valsartan—Muscle spasms—Etoposide—uterine cancer	0.00124	0.00218	CcSEcCtD
Valsartan—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00217	CcSEcCtD
Valsartan—Cardiac failure—Epirubicin—uterine cancer	0.00123	0.00216	CcSEcCtD
Valsartan—Nausea—Progesterone—uterine cancer	0.00122	0.00215	CcSEcCtD
Valsartan—Hyponatraemia—Epirubicin—uterine cancer	0.00121	0.00212	CcSEcCtD
Valsartan—Renal failure acute—Doxorubicin—uterine cancer	0.00121	0.00211	CcSEcCtD
Valsartan—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00119	0.00209	CcSEcCtD
Valsartan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00208	CcSEcCtD
Valsartan—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00207	CcSEcCtD
Valsartan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00206	CcSEcCtD
Valsartan—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00205	CcSEcCtD
Valsartan—Renal impairment—Doxorubicin—uterine cancer	0.00117	0.00205	CcSEcCtD
Valsartan—Dermatitis bullous—Doxorubicin—uterine cancer	0.00116	0.00204	CcSEcCtD
Valsartan—Vertigo—Etoposide—uterine cancer	0.00116	0.00204	CcSEcCtD
Valsartan—Abdominal pain—Dactinomycin—uterine cancer	0.00115	0.00202	CcSEcCtD
Valsartan—Cardiac failure—Doxorubicin—uterine cancer	0.00114	0.002	CcSEcCtD
Valsartan—Loss of consciousness—Etoposide—uterine cancer	0.00114	0.00199	CcSEcCtD
Valsartan—Cough—Etoposide—uterine cancer	0.00113	0.00198	CcSEcCtD
Valsartan—Blood creatinine increased—Epirubicin—uterine cancer	0.00113	0.00198	CcSEcCtD
Valsartan—Hyponatraemia—Doxorubicin—uterine cancer	0.00112	0.00196	CcSEcCtD
Valsartan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00195	CcSEcCtD
Valsartan—Chest pain—Etoposide—uterine cancer	0.0011	0.00193	CcSEcCtD
Valsartan—Abdominal pain upper—Epirubicin—uterine cancer	0.0011	0.00193	CcSEcCtD
Valsartan—Orthostatic hypotension—Epirubicin—uterine cancer	0.0011	0.00193	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00109	0.00192	CcSEcCtD
Valsartan—Hypersensitivity—Dactinomycin—uterine cancer	0.00107	0.00188	CcSEcCtD
Valsartan—Muscular weakness—Epirubicin—uterine cancer	0.00106	0.00186	CcSEcCtD
Valsartan—Anaphylactic shock—Etoposide—uterine cancer	0.00105	0.00185	CcSEcCtD
Valsartan—Infection—Etoposide—uterine cancer	0.00105	0.00184	CcSEcCtD
Valsartan—Asthenia—Dactinomycin—uterine cancer	0.00105	0.00183	CcSEcCtD
Valsartan—Blood creatinine increased—Doxorubicin—uterine cancer	0.00104	0.00183	CcSEcCtD
Valsartan—Thrombocytopenia—Etoposide—uterine cancer	0.00103	0.00181	CcSEcCtD
Valsartan—Skin disorder—Etoposide—uterine cancer	0.00102	0.0018	CcSEcCtD
Valsartan—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00102	0.00178	CcSEcCtD
Valsartan—Abdominal pain upper—Doxorubicin—uterine cancer	0.00102	0.00178	CcSEcCtD
Valsartan—Anorexia—Etoposide—uterine cancer	0.00101	0.00176	CcSEcCtD
Valsartan—Bronchitis—Epirubicin—uterine cancer	0.001	0.00175	CcSEcCtD
Valsartan—Diarrhoea—Dactinomycin—uterine cancer	0.000997	0.00175	CcSEcCtD
Valsartan—Hypotension—Etoposide—uterine cancer	0.000986	0.00173	CcSEcCtD
Valsartan—Muscular weakness—Doxorubicin—uterine cancer	0.000982	0.00172	CcSEcCtD
Valsartan—Neutropenia—Epirubicin—uterine cancer	0.000972	0.0017	CcSEcCtD
Valsartan—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000966	0.00169	CcSEcCtD
Valsartan—Photosensitivity reaction—Epirubicin—uterine cancer	0.000949	0.00166	CcSEcCtD
Valsartan—Paraesthesia—Etoposide—uterine cancer	0.000947	0.00166	CcSEcCtD
Valsartan—Dyspnoea—Etoposide—uterine cancer	0.000941	0.00165	CcSEcCtD
Valsartan—Somnolence—Etoposide—uterine cancer	0.000938	0.00164	CcSEcCtD
Valsartan—Infestation NOS—Epirubicin—uterine cancer	0.000927	0.00163	CcSEcCtD
Valsartan—Infestation—Epirubicin—uterine cancer	0.000927	0.00163	CcSEcCtD
Valsartan—Vomiting—Dactinomycin—uterine cancer	0.000927	0.00162	CcSEcCtD
Valsartan—Bronchitis—Doxorubicin—uterine cancer	0.000925	0.00162	CcSEcCtD
Valsartan—Rash—Dactinomycin—uterine cancer	0.000919	0.00161	CcSEcCtD
Valsartan—Decreased appetite—Etoposide—uterine cancer	0.000917	0.00161	CcSEcCtD
Valsartan—Renal failure—Epirubicin—uterine cancer	0.000911	0.0016	CcSEcCtD
Valsartan—Gastrointestinal disorder—Etoposide—uterine cancer	0.000911	0.0016	CcSEcCtD
Valsartan—Fatigue—Etoposide—uterine cancer	0.00091	0.00159	CcSEcCtD
Valsartan—Constipation—Etoposide—uterine cancer	0.000902	0.00158	CcSEcCtD
Valsartan—Neutropenia—Doxorubicin—uterine cancer	0.0009	0.00158	CcSEcCtD
Valsartan—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000894	0.00157	CcSEcCtD
Valsartan—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000878	0.00154	CcSEcCtD
Valsartan—Epistaxis—Epirubicin—uterine cancer	0.000875	0.00153	CcSEcCtD
Valsartan—Sinusitis—Epirubicin—uterine cancer	0.00087	0.00152	CcSEcCtD
Valsartan—Nausea—Dactinomycin—uterine cancer	0.000866	0.00152	CcSEcCtD
Valsartan—Gastrointestinal pain—Etoposide—uterine cancer	0.000863	0.00151	CcSEcCtD
Valsartan—Infestation NOS—Doxorubicin—uterine cancer	0.000858	0.0015	CcSEcCtD
Valsartan—Infestation—Doxorubicin—uterine cancer	0.000858	0.0015	CcSEcCtD
Valsartan—Renal failure—Doxorubicin—uterine cancer	0.000843	0.00148	CcSEcCtD
Valsartan—Urticaria—Etoposide—uterine cancer	0.000838	0.00147	CcSEcCtD
Valsartan—Haemoglobin—Epirubicin—uterine cancer	0.000837	0.00147	CcSEcCtD
Valsartan—Rhinitis—Epirubicin—uterine cancer	0.000834	0.00146	CcSEcCtD
Valsartan—Abdominal pain—Etoposide—uterine cancer	0.000834	0.00146	CcSEcCtD
Valsartan—Hepatitis—Epirubicin—uterine cancer	0.000832	0.00146	CcSEcCtD
Valsartan—Haemorrhage—Epirubicin—uterine cancer	0.000832	0.00146	CcSEcCtD
Valsartan—Pharyngitis—Epirubicin—uterine cancer	0.000826	0.00145	CcSEcCtD
Valsartan—Urinary tract disorder—Epirubicin—uterine cancer	0.000822	0.00144	CcSEcCtD
Valsartan—Connective tissue disorder—Epirubicin—uterine cancer	0.000818	0.00143	CcSEcCtD
Valsartan—Urethral disorder—Epirubicin—uterine cancer	0.000816	0.00143	CcSEcCtD
Valsartan—Epistaxis—Doxorubicin—uterine cancer	0.000809	0.00142	CcSEcCtD
Valsartan—Sinusitis—Doxorubicin—uterine cancer	0.000805	0.00141	CcSEcCtD
Valsartan—Hypersensitivity—Etoposide—uterine cancer	0.000777	0.00136	CcSEcCtD
Valsartan—Haemoglobin—Doxorubicin—uterine cancer	0.000774	0.00136	CcSEcCtD
Valsartan—Cardiac disorder—Epirubicin—uterine cancer	0.000772	0.00135	CcSEcCtD
Valsartan—Rhinitis—Doxorubicin—uterine cancer	0.000772	0.00135	CcSEcCtD
Valsartan—Hepatitis—Doxorubicin—uterine cancer	0.00077	0.00135	CcSEcCtD
Valsartan—Haemorrhage—Doxorubicin—uterine cancer	0.00077	0.00135	CcSEcCtD
Valsartan—Pharyngitis—Doxorubicin—uterine cancer	0.000764	0.00134	CcSEcCtD
Valsartan—Urinary tract disorder—Doxorubicin—uterine cancer	0.000761	0.00133	CcSEcCtD
Valsartan—Asthenia—Etoposide—uterine cancer	0.000757	0.00133	CcSEcCtD
Valsartan—Connective tissue disorder—Doxorubicin—uterine cancer	0.000757	0.00133	CcSEcCtD
Valsartan—Angiopathy—Epirubicin—uterine cancer	0.000755	0.00132	CcSEcCtD
Valsartan—Urethral disorder—Doxorubicin—uterine cancer	0.000755	0.00132	CcSEcCtD
Valsartan—Immune system disorder—Epirubicin—uterine cancer	0.000752	0.00132	CcSEcCtD
Valsartan—Mediastinal disorder—Epirubicin—uterine cancer	0.00075	0.00132	CcSEcCtD
Valsartan—Pruritus—Etoposide—uterine cancer	0.000746	0.00131	CcSEcCtD
Valsartan—Alopecia—Epirubicin—uterine cancer	0.000736	0.00129	CcSEcCtD
Valsartan—Mental disorder—Epirubicin—uterine cancer	0.000729	0.00128	CcSEcCtD
Valsartan—Malnutrition—Epirubicin—uterine cancer	0.000725	0.00127	CcSEcCtD
Valsartan—Diarrhoea—Etoposide—uterine cancer	0.000722	0.00127	CcSEcCtD
Valsartan—Cardiac disorder—Doxorubicin—uterine cancer	0.000715	0.00125	CcSEcCtD
Valsartan—Flatulence—Epirubicin—uterine cancer	0.000714	0.00125	CcSEcCtD
Valsartan—Dysgeusia—Epirubicin—uterine cancer	0.00071	0.00124	CcSEcCtD
Valsartan—Back pain—Epirubicin—uterine cancer	0.000701	0.00123	CcSEcCtD
Valsartan—Angiopathy—Doxorubicin—uterine cancer	0.000699	0.00122	CcSEcCtD
Valsartan—Dizziness—Etoposide—uterine cancer	0.000698	0.00122	CcSEcCtD
Valsartan—Muscle spasms—Epirubicin—uterine cancer	0.000697	0.00122	CcSEcCtD
Valsartan—Immune system disorder—Doxorubicin—uterine cancer	0.000696	0.00122	CcSEcCtD
Valsartan—Mediastinal disorder—Doxorubicin—uterine cancer	0.000694	0.00122	CcSEcCtD
Valsartan—Vision blurred—Epirubicin—uterine cancer	0.000683	0.0012	CcSEcCtD
Valsartan—Alopecia—Doxorubicin—uterine cancer	0.000681	0.00119	CcSEcCtD
Valsartan—Mental disorder—Doxorubicin—uterine cancer	0.000675	0.00118	CcSEcCtD
Valsartan—Vomiting—Etoposide—uterine cancer	0.000671	0.00118	CcSEcCtD
Valsartan—Malnutrition—Doxorubicin—uterine cancer	0.00067	0.00118	CcSEcCtD
Valsartan—Rash—Etoposide—uterine cancer	0.000665	0.00117	CcSEcCtD
Valsartan—Dermatitis—Etoposide—uterine cancer	0.000665	0.00117	CcSEcCtD
Valsartan—Headache—Etoposide—uterine cancer	0.000661	0.00116	CcSEcCtD
Valsartan—Flatulence—Doxorubicin—uterine cancer	0.000661	0.00116	CcSEcCtD
Valsartan—Dysgeusia—Doxorubicin—uterine cancer	0.000657	0.00115	CcSEcCtD
Valsartan—Vertigo—Epirubicin—uterine cancer	0.000651	0.00114	CcSEcCtD
Valsartan—Syncope—Epirubicin—uterine cancer	0.00065	0.00114	CcSEcCtD
Valsartan—Back pain—Doxorubicin—uterine cancer	0.000649	0.00114	CcSEcCtD
Valsartan—Muscle spasms—Doxorubicin—uterine cancer	0.000645	0.00113	CcSEcCtD
Valsartan—Palpitations—Epirubicin—uterine cancer	0.00064	0.00112	CcSEcCtD
Valsartan—Loss of consciousness—Epirubicin—uterine cancer	0.000637	0.00112	CcSEcCtD
Valsartan—Cough—Epirubicin—uterine cancer	0.000632	0.00111	CcSEcCtD
Valsartan—Vision blurred—Doxorubicin—uterine cancer	0.000632	0.00111	CcSEcCtD
Valsartan—Nausea—Etoposide—uterine cancer	0.000627	0.0011	CcSEcCtD
Valsartan—Myalgia—Epirubicin—uterine cancer	0.000617	0.00108	CcSEcCtD
Valsartan—Chest pain—Epirubicin—uterine cancer	0.000617	0.00108	CcSEcCtD
Valsartan—Arthralgia—Epirubicin—uterine cancer	0.000617	0.00108	CcSEcCtD
Valsartan—Anxiety—Epirubicin—uterine cancer	0.000615	0.00108	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000613	0.00107	CcSEcCtD
Valsartan—Dry mouth—Epirubicin—uterine cancer	0.000603	0.00106	CcSEcCtD
Valsartan—Vertigo—Doxorubicin—uterine cancer	0.000602	0.00106	CcSEcCtD
Valsartan—Syncope—Doxorubicin—uterine cancer	0.000601	0.00105	CcSEcCtD
Valsartan—Palpitations—Doxorubicin—uterine cancer	0.000592	0.00104	CcSEcCtD
Valsartan—Anaphylactic shock—Epirubicin—uterine cancer	0.000591	0.00104	CcSEcCtD
Valsartan—Oedema—Epirubicin—uterine cancer	0.000591	0.00104	CcSEcCtD
Valsartan—Loss of consciousness—Doxorubicin—uterine cancer	0.000589	0.00103	CcSEcCtD
Valsartan—Infection—Epirubicin—uterine cancer	0.000587	0.00103	CcSEcCtD
Valsartan—Cough—Doxorubicin—uterine cancer	0.000585	0.00103	CcSEcCtD
Valsartan—Shock—Epirubicin—uterine cancer	0.000582	0.00102	CcSEcCtD
Valsartan—Nervous system disorder—Epirubicin—uterine cancer	0.00058	0.00102	CcSEcCtD
Valsartan—Thrombocytopenia—Epirubicin—uterine cancer	0.000579	0.00102	CcSEcCtD
Valsartan—Skin disorder—Epirubicin—uterine cancer	0.000574	0.00101	CcSEcCtD
Valsartan—Arthralgia—Doxorubicin—uterine cancer	0.000571	0.001	CcSEcCtD
Valsartan—Myalgia—Doxorubicin—uterine cancer	0.000571	0.001	CcSEcCtD
Valsartan—Chest pain—Doxorubicin—uterine cancer	0.000571	0.001	CcSEcCtD
Valsartan—Anxiety—Doxorubicin—uterine cancer	0.000569	0.000997	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000567	0.000994	CcSEcCtD
Valsartan—Anorexia—Epirubicin—uterine cancer	0.000564	0.000988	CcSEcCtD
Valsartan—Dry mouth—Doxorubicin—uterine cancer	0.000558	0.000979	CcSEcCtD
Valsartan—Hypotension—Epirubicin—uterine cancer	0.000553	0.000969	CcSEcCtD
Valsartan—Anaphylactic shock—Doxorubicin—uterine cancer	0.000547	0.000959	CcSEcCtD
Valsartan—Oedema—Doxorubicin—uterine cancer	0.000547	0.000959	CcSEcCtD
Valsartan—Infection—Doxorubicin—uterine cancer	0.000544	0.000953	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000539	0.000945	CcSEcCtD
Valsartan—Shock—Doxorubicin—uterine cancer	0.000538	0.000944	CcSEcCtD
Valsartan—Nervous system disorder—Doxorubicin—uterine cancer	0.000537	0.000941	CcSEcCtD
Valsartan—Thrombocytopenia—Doxorubicin—uterine cancer	0.000536	0.000939	CcSEcCtD
Valsartan—Insomnia—Epirubicin—uterine cancer	0.000535	0.000938	CcSEcCtD
Valsartan—Skin disorder—Doxorubicin—uterine cancer	0.000531	0.000932	CcSEcCtD
Valsartan—Paraesthesia—Epirubicin—uterine cancer	0.000531	0.000931	CcSEcCtD
Valsartan—Dyspnoea—Epirubicin—uterine cancer	0.000527	0.000924	CcSEcCtD
Valsartan—Somnolence—Epirubicin—uterine cancer	0.000526	0.000922	CcSEcCtD
Valsartan—Anorexia—Doxorubicin—uterine cancer	0.000522	0.000914	CcSEcCtD
Valsartan—Dyspepsia—Epirubicin—uterine cancer	0.000521	0.000913	CcSEcCtD
Valsartan—Decreased appetite—Epirubicin—uterine cancer	0.000514	0.000901	CcSEcCtD
Valsartan—Hypotension—Doxorubicin—uterine cancer	0.000511	0.000896	CcSEcCtD
Valsartan—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000511	0.000895	CcSEcCtD
Valsartan—Fatigue—Epirubicin—uterine cancer	0.00051	0.000894	CcSEcCtD
Valsartan—Constipation—Epirubicin—uterine cancer	0.000506	0.000887	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000499	0.000874	CcSEcCtD
Valsartan—Insomnia—Doxorubicin—uterine cancer	0.000495	0.000868	CcSEcCtD
Valsartan—Paraesthesia—Doxorubicin—uterine cancer	0.000491	0.000861	CcSEcCtD
Valsartan—Dyspnoea—Doxorubicin—uterine cancer	0.000488	0.000855	CcSEcCtD
Valsartan—Somnolence—Doxorubicin—uterine cancer	0.000486	0.000853	CcSEcCtD
Valsartan—Gastrointestinal pain—Epirubicin—uterine cancer	0.000484	0.000848	CcSEcCtD
Valsartan—Dyspepsia—Doxorubicin—uterine cancer	0.000482	0.000844	CcSEcCtD
Valsartan—Decreased appetite—Doxorubicin—uterine cancer	0.000476	0.000834	CcSEcCtD
Valsartan—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000472	0.000828	CcSEcCtD
Valsartan—Fatigue—Doxorubicin—uterine cancer	0.000472	0.000827	CcSEcCtD
Valsartan—Urticaria—Epirubicin—uterine cancer	0.00047	0.000824	CcSEcCtD
Valsartan—Constipation—Doxorubicin—uterine cancer	0.000468	0.00082	CcSEcCtD
Valsartan—Abdominal pain—Epirubicin—uterine cancer	0.000467	0.00082	CcSEcCtD
Valsartan—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000447	0.000784	CcSEcCtD
Valsartan—Hypersensitivity—Epirubicin—uterine cancer	0.000436	0.000764	CcSEcCtD
Valsartan—Urticaria—Doxorubicin—uterine cancer	0.000435	0.000762	CcSEcCtD
Valsartan—Abdominal pain—Doxorubicin—uterine cancer	0.000433	0.000758	CcSEcCtD
Valsartan—Asthenia—Epirubicin—uterine cancer	0.000424	0.000744	CcSEcCtD
Valsartan—Pruritus—Epirubicin—uterine cancer	0.000418	0.000733	CcSEcCtD
Valsartan—Diarrhoea—Epirubicin—uterine cancer	0.000405	0.000709	CcSEcCtD
Valsartan—Hypersensitivity—Doxorubicin—uterine cancer	0.000403	0.000707	CcSEcCtD
Valsartan—Asthenia—Doxorubicin—uterine cancer	0.000393	0.000688	CcSEcCtD
Valsartan—Dizziness—Epirubicin—uterine cancer	0.000391	0.000686	CcSEcCtD
Valsartan—Pruritus—Doxorubicin—uterine cancer	0.000387	0.000679	CcSEcCtD
Valsartan—Vomiting—Epirubicin—uterine cancer	0.000376	0.000659	CcSEcCtD
Valsartan—Diarrhoea—Doxorubicin—uterine cancer	0.000374	0.000656	CcSEcCtD
Valsartan—Rash—Epirubicin—uterine cancer	0.000373	0.000654	CcSEcCtD
Valsartan—Dermatitis—Epirubicin—uterine cancer	0.000373	0.000653	CcSEcCtD
Valsartan—Headache—Epirubicin—uterine cancer	0.00037	0.000649	CcSEcCtD
Valsartan—Dizziness—Doxorubicin—uterine cancer	0.000362	0.000634	CcSEcCtD
Valsartan—Nausea—Epirubicin—uterine cancer	0.000351	0.000616	CcSEcCtD
Valsartan—Vomiting—Doxorubicin—uterine cancer	0.000348	0.00061	CcSEcCtD
Valsartan—Rash—Doxorubicin—uterine cancer	0.000345	0.000605	CcSEcCtD
Valsartan—Dermatitis—Doxorubicin—uterine cancer	0.000345	0.000604	CcSEcCtD
Valsartan—Headache—Doxorubicin—uterine cancer	0.000343	0.000601	CcSEcCtD
Valsartan—Nausea—Doxorubicin—uterine cancer	0.000325	0.00057	CcSEcCtD
